BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Big Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2276.64 only $796.82

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,021.63
      0.57%
      US Tech 100
      20,372.40
      0.00%
      Dow Jones
      44,860.31
      0.28%
      Brent Oil
      72.535
      0.12%
      Bitcoin
      93,298.72
      1.45%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Dermata Therapeutics Inc (DRMA)

      7. Dermata Therapeutics Inc (DRMA) Financials

      Dermata Therapeutics Inc

      Dermata Therapeutics Inc (DRMA)

      NASDAQ
      1.1009
      0.00
      (0.00%)
      Closed November 27 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Dermata Therapeutics Inc Financial Summary

      The current DRMA market cap is 2.25M. The company's latest EPS is USD -3.8196 and P/E is -0.29.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -2.28M-1.73M-1.81M-2.22M-3.2M
      Net Income -2.24M-1.7M-1.72M-2.13M-3.13M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0000
      Operating Income -3.17M-7.86M-9.67M-8.04M
      Net Income -3.24M-7.9M-9.61M-7.8M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 9.3M8.71M7.32M7.98M5.18M
      Total Liabilities 1.21M683k916k1.62M1.37M
      Total Equity 8.09M8.03M6.41M6.36M3.81M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 605k11.62M6.94M7.98M
      Total Liabilities 3.78M1.52M922k1.62M
      Total Equity -3.18M10.11M6.02M6.36M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)
      Operating -1.65M-3.49M-5.26M-6.41M-2.7M
      Investing N/A N/A N/A N/A N/A
      Financing 4.18M5.69M5.65M7.61M N/A
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Operating -4.03M-5.69M-8.83M-6.41M
      Investing N/A N/A N/A N/A
      Financing 2.57M15.96M4.28M7.61M

      Stats and Ratios

      Market Cap 2.25M
      Price to Earnings Ratio -0.29
      Price to Sales Ratio 0
      Price to Cash Ratio 0.3
      Price to Book Ratio 0.35
      Dividend Yield -

      Share Statistics

      Shares Outstanding 2.04M
      Average Volume (1 week) 126.51k
      Average Volume (1 Month) 85.03k
      52 Week Change -88.88%
      52 Week High 13.35
      52 Week Low 1.0501
      Spread (Intraday) 0.19 (14.73%)

      Company Info

      Company Name Dermata Therapeutics Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.dermatarx.com
      Industry pharmaceutical preparations (2834)